|
| |
Pathology
although classically thought of as a disease of the peripheral nervous
system, there may be spinal cord changes on autopsy
Precipitating factors
Campylobacter jejuni infection precedes onset in up to 26-41% of sporadic
cases
viral infection
surgery/trauma
Clinical features
Diagnostic criteria
Features required for diagnosis
progressive motor weakness of > 1 limb
areflexia
Features strongly supportive of the diagnosis
Clinical (in order of importance)
- initial rapid progression of weakness but no further progression by 4
weeks
- symmetry seldom absolute but if one limb is affected opposite one is
likely to be affected
- mild sensory symptoms and signs
- facial weakness common (especially in axonal degeneration form) and
frequently bilateral. Other cranial nerves may be involved, particularly
those innervating tongue, muscles of deglutination and extraocular muscles
- recovery usually start 2-4 weeks after progression stops
- sinus tachycardia, other arrhythmias and labile BP
- absence of fever at onset of neuritic symptoms
CSF
- increased CSF protein after 1st week of symptoms or increases on serial
examinations
- 10 mononuclear leukocytes/ml
EMG
- approx 80% have evidence of nerve conduction slowing or blockage at some
point during illness. Neuropathy usually demyelinating but may be axonal
Respiratory dysfunction
impaired expiratory effort (cough)
weakness of tongue and retropharyngeal muscles causes positional airway
obstruction
inspiratory muscle weakness
increased risk of aspiration due to weakness of laryngeal and glottic
muscles
ventilatory drive and CO2 response generally normal
Assessment of respiratory function
respiratory dysfunction may be compromised before clinical signs are
clinically obvious
ventilatory muscle insufficiency may not correlate well with general
neuromuscular examination
serial assessment is essential to ensure prompt transfer of patients to ICU
at the onset of ventilatory failure
respiratory rate
paradoxical abdominal movement
frequent changes in breathing pattern to alternate between major and
accessory respiratory muscles
use of accessory muscles during quiet breathing
cough
ability to protect airway: nasal speech, difficulty with protruding tongue
and difficulty swallowing indicate that bulbar involvement is significant and
ventilatory failure is imminent
presence of atelectasis or pulmonary infiltrates on CXR suggest rapidly
evolving ventilatory failure
maximum inspiratory force < 20 cm H2O associated with high
risk of ventilatory insufficiency
FVC < 15 ml/kg associated with increased risk of ventilatory failure,
< 10 indicative of ventilatory failure
ABG: changes occur late
Autonomic dysfunction
cardiac arrhythmias
labile BP
abnormal haemodynamic response to drugs
ECG abnormalities
pupillary dysfunction
sweating abnormalities
urinary retention
GI dysfunction
blood volume and electrolyte disturbances are common due to loss of
autonomic control of systemic blood flow distribution, renin and aldosterone
release and fluid loss from sweat glands
Clinical forms
Acute inflammatory demyelinating polyradiculopathy
most prominent form
segmental loss of myelin in spinal roots and peripheral nerves
- slowing of nerve conduction velocites
- prolongation of distal and F wave latencies
- conduction block
- once immune reactions come to a halt, repair and remyelination set in
quickly. Correlates with quick and usually complete recovery.
- In some, particularly those with severe disease inflammatory demyelination
is accompanied by variable disruption and loss of axons. Degree of
complicating axonal loss is an important determinant of speed of recovery,
lasting deficits and ultimately prognosis
Acute motor-sensory axonal neuropathy
Fulminant onset of severe paralysis and sensory deficits
Acute axonal degeneration
¯ ¯ ¯
or absent evoked responses on distal supramaximal stimulation of motor and
sensory nerves. Progresses rapidly to total loss of electrical excitability.
Acute motor-axonal neuropathy
10-20% of sporadic cases
¯ /absent distally evoked compound motor action
potentials (early sign of denervation) but normal conduction velocities and
active potentials in sensory nerves
predominantly affects motor nerve terminals
Miller-Fisher syndrome
affects nodal regions of oculomotor nerves, dorsal root ganglion cells and
cerebellar neurons
ophthalmoplegia
ataxia
areflexia
Treatment
Plasmapheresis
decreases time on a mechanical ventilation
should be applied early
1.5-2 plasma volumes on alternate days. 2 treatments for those with mild
disease and 4 for those with moderate or severe disease
early completion of plasmapheresis may be followed by relapses, which may
respond to further plasma exchange
Immunoglobulin
IV pooled gamma globulin (0.4
g/kg/day) given in the first 2 weeks of the disease is as effective as
plasmapheresis.
IV IgG should now be treatment of choice for patients with severe GBS during
the first 2 weeks after start of neuropathic symptoms on grounds of equivalent
efficacy, similar cost, greater convenience and ease of administration
Limited relapses in ~10%. Most respond to repeated course.
Supportive
General: DVT prophylaxis, good neuro and chest physio, psychological
support, communication aids
Respiratory
- some evidence that early intubation and ventilation reduces pulmonary
complications
- objective criteria for ventilation include FVC < 10 ml/kg and maximum
inspiratory force < 30 cm H2O. Do not rely on ABGs. May
require intubation at FVC <15 ml/kg due to inability to clear secretions
- decision with regard to tracheostomy may be best left until after
plasmapheresis is completed, at which time disease course can be predicted
more easily. Apporximately 1/3 of patients no longer need intubation after 2
weeks
Cardiac
symptomatic bradycardia, complete heart block and cardiac arrest are
indications for insertion of temporary pacing wire
caution with vasodilators and anaesthetics in view of inability to increase
cardiac output in response to vasodilatation
Pain
may be related to pressure areas and may be partially relieved by sheepskins
and frequent turning
socks and warming devices may give some relief
NSAIDs may help joint aches and pains but opioids usually necessary
antidepressants may be used as an adjuvant to manage sleep disturbance,
paraesthetic pain and emotional consequences of illness
epidural opioids may be useful in controlling pain unresponsive to
conventional methods
Prognosis
~75% of patients reach nadir within 2 weeks, 92% within 3 weeks and 94%
within 4 weeks
outcome generally favourable
most reliable indicators of significant residual disability at 1 year:
- age >60 yrs
- progression to quadraplegia in <1 week
- mean distal motor amplitude <20% of lower limit of normal
- preceding diarrhoeal illness
Further reading
Hund EF, Borel CO, Cornblath DR, Hanley DF, McKhann GM. Intensive management
and treatment of severe Guillain-Barré syndrome. Crit Care Med, 1993;21:433-46
Nathan BR. Nervous system infections and parainfectious disorders. Current
Opinion in Critical Care, 1998; 4:76-82
© Charles Gomersall December 1999
|